Tuesday, September 15, 2020

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while...
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popcorn Time Updater Flaw Put Up to 350,000 Macs at Risk, Researchers Warn

Cybersecurity researchers at Eye Research found a vulnerability in Time4Popcorn, an unofficial version of Popcorn Time, that could allow att...